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Voluntary medical male circumcision (VMMC) 
reduces female-to-male transmission of HIV by 38% 
to 66% over 24 months[1] and is a priority preventive 
intervention for the World Health Organization 
(WHO)[2] and the US President’s Emergency Plan for 
AIDS Relief (PEPFAR). [3] In South Africa (SA), the national strategic 
plan for 2012 to 2016 calls for circumcising 80% of men between 15 
and 49 years of age (4.3 million men). If this goal is met,  more than 
1 million new HIV infections can be averted with overall net savings 
of US$5.5  billion between 2011 and 2025. [4] Thus far, the health 
department is behind on its target and is unlikely to achieve these 
goals unless additional modalities can help to scale up the medical 
circumcision process.[5] 
Open surgery with suturing is the standard technique currently used in 
most VMMC programmes. Unfortunately, it is time-consuming, requires 
good surgical skills, and minor complications are common under the 
programmatic conditions existing in Africa.[6] We have previously shown 
that VMMC using the Gomco instrument to excise the foreskin and 
sealing the wound with tissue adhesive is faster, easier, and has superior 
cosmetic results compared with open surgical circumcision. [7]
Objective
To compare conventional open surgical circumcision with suturing 
to a minimally invasive technique using a single-use-only disposable 
instrument (Unicirc) plus tissue adhesive. This technique completes 
the circumcision at the time of surgery, and requires no further visits 
for device removal. We hypothesised that the new technique would 
be superior to open surgical VMMC with regard to intraoperative 
time, ease of performance, and have similar adverse events. 
Methods
Trial design
This was a single-centre non-blinded randomised controlled trial 
with 2:1 (Unicirc:surgical) allocation ratio in balanced blocks of 15, 
following the guidelines of the WHO Framework for Clinical Evaluation 
of Devices for Adult Male Circumcision.[8] An investigator (HRW), who 
was not involved in the surgeries, allocated participants in a 2:1 ratio 
in blocks of 15 using a random number table. Slips of paper with the 
group assignment were folded and placed in sealed, opaque envelopes. 
Each envelope was opened only at the time of surgery. We used the 
sample size recommended in the WHO Framework.[8] The sample size 
of 150 (50 surgical and 100 Unicirc) gave us >90% power to detect a 
mean difference of 8 min in duration of surgery. 
The South African Medical Association’s Ethics Committee 
(SAMAREC) approved the study. The ClinicalTrials.gov identifier is 
NCT01877408. All subjects gave informed consent. The study took 
place between 21 June and 8 August 2013.
Participants
Healthy uncircumcised men of at least 18 years of age were eligible 
for the study. Participants were recruited via posters at two affiliated 
primary healthcare clinics in Cape Town, SA.
Exclusion criteria were concurrent illness, history of bleeding 
disorder, past reaction to local anaesthetic, infection, or penile 
abnormality that would complicate circumcision. Men with complete 
phimosis were excluded from the study, but we included men with 
partial phimosis without adhesions. We included men with scarring 
of the frenulum, because it is a common condition easily corrected at 
the time of circumcision. 
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Participants received HIV prevention counselling. We offered HIV 
testing, but did not request testing as a study prerequisite. The ethics 
panel advised us not to require a test for HIV (and therefore exclude 
HIV-positive men), because this was a study of a surgical procedure, 
not a study of whether or not circumcision prevents HIV. Participants 
were advised to abstain from sexual intercourse until the wound was 
completely healed and for at least 4 weeks after the circumcision. 
Condoms were made freely available.
Intervention
Four generalist doctors, assisted by registered nurses, performed the 
circumcisions in individual consultation rooms in a single primary 
healthcare clinic on four different dates.
We used a mixture of 2% lidocaine with marcaine local anaesthesia 
as a subcutaneous ring block at the base of the penis as per the WHO 
Manual for Male Circumcision under Local Anaesthesia.[9] 
One of the following interventions was performed:
• Open surgical technique. We used the dorsal slit technique, the 
sleeve technique, or the forceps-guided technique according 
to doctor preference as described in the WHO manual.[9] After 
suturing, the wound was covered with an absorbent gauze dressing.
• Unicirc with cyanoacrylate skin adhesive. The Unicirc is a plastic and 
metal single-use-only disposable instrument designed in SA. The 
instruments were gas sterilised in sealed packages. After applying the 
Unicirc instrument to the foreskin, we waited 5 min before excising 
the foreskin with a surgical scalpel. We then removed the instrument 
and sealed the apposed skin-mucosal edges with cyanoacrylate skin 
adhesive. We used four different Unicirc sizes in this study: 2.6 cm, 
2.9 cm, 3.2 cm and 3.5 cm. We covered the wound with an adherent 
tape (Hypafix) and absorbent gauze. We removed the absorbent gauze 
at the two-day follow-up visit, and instructed participants to keep the 
wound dry and to leave the adherent tape in place for two weeks.
All men were observed for 20 min after the procedure. Subjects were 
given written post-operative instructions and cellular telephone 
contact information of the doctor. 
Outcome measures
• Primary. Intraoperative time.
• Secondary. Doctor-described ease in performing the technique, 
estimated blood loss, complications (operative and post-operative), 
post-operative pain, time to healing, patient satisfaction, cosmetic 
result, and direct costs of expendable materials.
• Key adverse events considered were anaesthetic complications, 
bleeding, haematoma, infection, wound disruption, problems 
with urination, subsequent procedures conducted to correct 
complications, and occupational exposure to blood and body 
fluids. We used standardised definitions to grade adverse events as 
mild, moderate or severe, using the WHO Framework for Clinical 
Evaluation of Devices for Adult Male Circumcision.[8] In brief, 
adverse events were categorised as mild if they required little or 
no intervention (e.g. mild wound disruption or slight bleeding), 
moderate if they required active treatment (e.g. antibiotics or 
suturing), or severe if they required transfusion or hospitalisation, 
or resulted in permanent damage. 
• Costs. Direct costs of expendable material.
Outcome definitions are shown in our previous publication.[7] Wound 
healing outcomes were assessed by the principal investigator (PSM), 
a co-author (NG) and one of the surgeons (Dr Senzo Ntshalintshali). 
Follow-up
Follow-up was at 2 days, 7 days, 2 weeks, and 4 weeks. For those 
men who were not completely healed by 4 weeks, we conducted an 
additional 6-week follow-up visit. 
Data analysis 
We collected data from participants on socio-demographics and 
circumcision knowledge/attitudes, and from participating doctors on 
ease of performing the surgery. We used a 10-point visual analogue 
scale for pain evaluation in the first 48  h after circumcision and a 
5-point Likert scale to grade satisfaction.
We conducted: (i) analysis of baseline data to examine potential 
confounders; (ii) calculation of descriptive statistics of outcomes; and 
(iii) statistical tests of operative time, differences in scale (e.g. 5-point 
Likert and 10-point pain scale) and proportions. We analysed the 
data with Epi Info (version 7).
Results
Participant flow
We recruited participants from 31 May to 26 June 2013. The flow 
of participants in the study is shown in Fig. 1. A total of 184 men 
were interviewed and 150 (81.5%) participated in the study. All 
participants were circumcised using the method to which they were 
randomly allocated. 
Baseline data
The baseline characteristics of the participants are shown in Table 1. 
The majority of men gave improved hygiene as their motivation 
for circumcision, 5% cited reduction in infections. There were no 
significant differences in the baseline characteristics of the two groups.
Outcomes analysed
Operative outcomes are shown in Table 2; 17 (17%) of the Unicirc 
circumcisions required intraoperative suturing. Intraoperative 
time and blood loss (without frenulectomy) were less with the 
Unicirc/tissue adhesive technique, median 13 v. 22.6 min (p<0.001), 
respectively, and median 1 v. 5.5 ml (p<0.001), respectively.
Adverse events are shown in Table 3. There were no significant 
differences between the two groups in bleeding, haematoma or 
infection. Wound disruptions >2  cm occurred in 2 (2%) of the 
Unicirc circumcisions at one week, and 1 (1%) at 2 weeks. Wound 
disruptions were <5 mm in width, and none required surgical closure. 
Post-operative pain, healing time, participant satisfaction and cosmetic 
results are shown in Table 4. Post-operative pain scores were low in both 
groups. There were no differences in healing at 4 weeks or in patient 
satisfaction. All subjects were fully healed at 6 weeks. The cosmetic result 
was superior in the Unicirc group; a regular scar line was found in 80.6% 
of the Unicirc subjects v. 40.0% in the surgical group (p<0.001).
Cost of expendable material
For the surgical VMMCs, we used pre-sterilised disposable kits specified 
by the WHO in SA at a cost of US$15. For the Unicirc VMMCs, we used 
pre-sterilised disposable kits that did not contain sutures or suturing 
instruments, at a cost of US$4, and a single-use tube of tissue adhesive 
at US$5. The Unicirc device cost US$20. The other costs (e.g. local 
anaesthesia, bandages) were similar for the two methods.
The results from the doctors’ survey are shown in Table 5. Doctors 
found the Unicirc procedure easier to perform and preferred it to the 
open surgical technique. Three of the four doctors had significant 
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previous experience performing open 
surgical circumcisions. Among these three 
doctors, there were two glove perforations 
during the study. One experienced doctor 
cut himself with a scalpel while doing an 
open surgical circumcision. The doctor with 
limited prior experience reported >10 glove 
perforations during the study. 
Discussion
Circumcision scale-up in sub-Saharan Africa 
has been constrained by the time needed and 
technical difficulties of performing open 
surgical circumcision, the only method 
approved by PEPFAR. To more effectively 
scale-up services, we require fundamental 
improvements in current circumcision 
techniques. We need techniques that 
are rapid, easy to learn, performed with 
standard instruments, inexpensive, result 
in few complications, and provide excellent 
patient satisfaction and cosmetic results. 
New VMMC modalities – plastic rings 
which all share common characteristics – have 
recently received a great deal of publicity. [5] 
They are attractive because they require 
less skill to place and are more rapid than 
open surgery, but have a number of serious 
drawbacks.[10] They remain in place for 1 week, 
during which time the men have to tolerate the 
smell of necrotic tissue. Removal is unpleasant 
and takes more time than placement (10 min 
v. 7 min for the Prepex device).[11] Healing is by 
secondary intention, so it is delayed. A recent 
study of the Prepex device showed a mean 
healing time of 38 days post-procedure; 16% of 
men were not completely healed by 7 weeks.[12] 
Recent cost-effectiveness analyses concluded 
that the Prepex device is marginally more cost-
effective than open surgical circumcision.[11,13]
Our prior study showed that removal of 
the foreskin with the Gomco instrument and 
sealing the wound with tissue adhesive has 
important advantages over open surgical 
circumcision. It requires much less operative 
time, is easier to perform, has better cosmetic 
results, and is potentially safer because it 
does not require suturing. [7] However, the 
Gomco instrument has drawbacks that make 
it less than ideal for mass circumcisions in 
resource-limited settings. Given the history of 
transmission of blood-borne infections from 
poorly sterilised instruments, WHO prefers 
disposable devices, but the Gomco instrument 
is re-usable and sterilisable. Given that the 
Gomco instrument consists of three different 
parts, mismatching parts from different-sized 
instruments or different manufacturers may 
potentially cause complications.
The Unicirc shares the advantages of the 
Gomco instrument, but it overcomes the 
above drawbacks. It is a metal and plastic 
instrument that is designed with threads that 
self-destruct after a single use, definitively 
preventing re-use. Because it is pre-packaged, 
mismatching of parts is not an issue.
The generalist doctors in this study were 
moderately experienced in open surgical 
circumcision but had not previously used the 
Gomco or Unicirc instruments. Operative 
times were much shorter with Unicirc v. surgical 
VMMC (13 v. 22.6  min, respectively). Using 
the WHO Models for Optimizing the Volume 
and Efficiency (MOVE) of task-sharing,[14] the 
actual time savings should be much greater 
than is reflected by this difference. It takes 1 - 
2 min to place the instrument, and 2 - 3 min to 
excise the foreskin, remove the instrument and 
apply the adhesive. The 5 min of waiting time 
while the compressive action takes place could 
be well used in other tasks. The time savings 
using the Unicirc/adhesive technique are likely 
to substantially reduce overall cost and assist in 
mass scale-up.
There were no serious adverse events in this 
study, and post-operative complications were 
similar in the two groups. However, 17% of 
the Unicirc subjects required intraoperative 
suturing, and there was a non-significant trend 
toward increased post-operative bleeding and 
haematoma with Unicirc. All post-operative 
bleeding occurred while the subjects were still 
in the clinic under post-operative supervision. 
Nonetheless, it was not an anticipated or 
desirable result and we did not find this in our 
prior experience with the prototype Unicirc 
device. We attribute the bleeding to shrinkage 
that occurred after the injection moulding 
of the plastic component of the Unicirc 
production instruments used in this study. 
We subsequently made minor revisions to 
the device to increase the compressive forces. 
After approval by SAMAREC, we conducted a 
further 50 Unicirc circumcisions in volunteers 
who had expressed an interest in the original 
study. None of the participants required 
intraoperative suturing, and we found a low 
rate of post-operative bleeding and haematoma 
with the revised Unicirc device (Table 6).
Unlike our previous study conducted 
during the rainy season in an impoverished 
community in Mozambique, adhesive failure 
was not a problem in this cohort. The SA 
participants had much more success in keeping 
the wound adhesive dry in the post-operative 
period. The inexpensive, Asian-manufactured 
Assessed for eligibility (N=184)
Randomised (N=150)
Allocation
Follow-up
Analysis
Unicirc circumcision (N=100)
Day 2: 100 (100%)
Day 7: 100 (100%)
Day 14: 98 (98%)
Day 28: 98 (98%)
Pain and complications (N=100)
 Day 2: 100 (100%)
 Day 7: 100 (100%)
 Day 14: 98 (98%)
 Day 28: 98 (98%)
Exit survey: 98 (98%)
Doctor’s survey: 4/4 (100%)
Surgical intervention (N=50)
Day 2: 50 (100%)
Day 7: 49 (98%)
Day 14: 49 (98%)
Day 28: 50 (100%)
Pain and complications (N=50)
 Day 2: 50 (100%)
 Day 7: 49 (98%)
 Day 14: 49 (98%)
 Day 28: 50 (100%)
Exit survey: 50 (100%)
Doctor’s survey: 4/4 (100%)
Excluded (34)
· Inclusion criteria not met (8)
· Declined to participate (26)
Fig. 1. Participant flow diagram.
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cyanoacrylate adhesive that we used was more difficult to apply because 
it had a lower viscosity than the cyanoacrylate adhesive that we used 
in our Mozambique study. In future studies, it would be worthwhile to 
compare the performance of other cyanoacrylate formulations.
The cost of expendable materials was similar using the two techniques. 
The cost of tissue adhesive approximates the cost of suture materials. 
Unicirc requires fewer disposable instruments (only one haemostat 
and one scalpel) and this nearly compensated for the cost of the 
Unicirc device. Because the Unicirc procedure requires no follow-up 
visits, we expect there to be significant cost savings compared with 
plastic ring devices, such as the Shang Ring and PrePex. Plastic ring 
devices also require both an application pack and a removal pack, 
which contains scissors and a device for removing the ring.
There were several glove perforations among doctors during the study, 
and one doctor injured himself with a scalpel. Because the Unicirc/
adhesive technique requires no sutures, there is no possibility of a needle-
stick injury from a suture needle. All doctors preferred the Unicirc 
method to the surgical method, citing ease of performance and shorter 
intraoperative time as advantages of the Unicirc. 
No one technique will be suitable for all settings. The Unicirc/tissue 
adhesive procedure is ideal for outpatient settings, where large numbers 
of circumcisions are performed by mid-level staff using the MOVE 
model, or for use by private practitioners who have basic surgical skills 
and wish to add circumcision services to their practice. Because of 
the potential need for intraoperative and post-operative suturing, the 
procedure is not suitable for rural clinics that lack a provider skilled in 
basic surgical techniques. 
Study limitations
This study was non-blinded and was performed at a single centre. The 
estimated blood loss was subjectively estimated by the surgeons. There 
was no independent, objective measure of wound healing outcomes. 
Rather, these outcomes were assessed by the three different physicians, 
with close collaboration. Given the high follow-up rates, long opening 
hours of the primary healthcare clinic where the study was conducted, 
and the easy availability of doctors via cell phone, we think it unlikely that 
any adverse events were missed. Finally, the costs of expendable materials 
were underestimated in the Unicirc group, because of the unanticipated 
bleeding complications.
Conclusions
This study has important implications for the scale-up of VMMC 
services. Excising the foreskin after applying the Unicirc instrument 
for 5 min and sealing the wound with cyanoacrylate tissue adhesive 
in adults is quicker, easier to learn, has superior cosmetic results and 
is potentially safer than open surgical VMMC. Further studies should 
be conducted with the optimised device. Use of this new method 
should greatly facilitate scale-up of mass circumcision programmes. 
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Table 1. Baseline characteristics
Unicirc/adhesive* 
(N=100), n and %
Open surgical* 
(N=50), n (%)
Age (years)
18 - 25 21 12 (24)
36 - 35 49 21 (42)
≥36 30 17 (34)
Marital status
Single (in a relationship) 38 26 (52)
Married 53 17 (34)
No partner 9 7 (14)
Religion
Christian 74 33 (66)
Muslim 16 6 (12)
No religion 10 11 (22)
Education level
Primary 5 2 (4)
Secondary 91 45 (90)
Post-secondary 4 3 (6)
Reason for wanting 
circumcision
Hygiene 76 33 (66)
Reduce infections 5 3 (6)
Social/religious 16 8 (16)
Other 3 6 (12)
*p>0.05 for all comparisons.
Table 2. Intraoperative outcomes
Unicirc/
adhesive 
(N=100)
Open surgical 
(N=50)
Intraoperative suturing, n (%) 17 (17) All by protocol
Frenulectomy performed, n (%) 4 (4) 6 (12)
Intraoperative time (min), 
median (IQR)
With frenulectomy 28.6 (17.7) 25 (18) 
Without frenulectomy* 13 (4.5) 22.6 (8.6)
Estimated blood loss (ml), 
median (IQR)
With frenulectomy 6.5 (3.5) 10 (6.5)
Without frenulectomy* 1 (1) 5.5 (6.5) 
IQR = interquartile range.
*p<0.001.
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Table 3. Adverse events
Unicirc/
adhesive 
(N=100) 
n and %
Open 
surgical 
(N=50) 
n (%) p-value
Serious post-operative 
complication
0 0 -
Post-operative bleeding
Mild (dressing only) 4 1 (2) 0.25
Moderate (sutured) 10 2 (4)
Haematoma 4 0 0.15
Post-operative infection 
(antibiotic required)
10 6 (12) 0.71
Wound disruption at 2 days 
(cm length)
<2 2 1 (2) 1
>2 0 0
Wound disruption at 1 week 
(cm length)
<2 6 1 (2) 0.15
>2 2 0
Wound disruption at 2 weeks 
(cm length)
<2 8 2 (4) 0.27
>2 1 0
Table 4. Post-operative outcomes
Unicirc/
adhesive 
(N=100)
Open 
surgical 
(N=50) p-value
Pain (10-point scale),  
mean (±SD)
In first 24 h 4.2 (±2.7) 3.1 (±2.4) 0.01
At 48 h visit 0.7 (±1.6) 1.2 (±2) 0.04
Wound fully healed, n (%)
At 2 weeks 0 0
At 4 weeks 89 (90.8) 49 (98) 0.1
Sexually active at 4 weeks, 
n (%)
22 (22) 6 (12) 0.14
Satisfaction, n (%)
Very satisfied 78 (79.6) 40 (80)
Satisfied 15 (15.3) 8 (16)
Not satisfied 5 (5.1) 2 (4) 0.9
Recommendation, n (%)
Recommend highly 91 (92.9) 48 (96) 0.46
Recommend 4 (4) 1 (2)
Not recommend 3 (3.1) 1 (2)
Cosmetic results, n (%)
Regular 79 (80.6) 20 (40) < 0.001
Irregular 12 (12.2) 8 (16)
Scalloped 7 (7.1) 22 (44)
Table 5. Doctors’ survey
Generalist physicians 
(N=4)
Circumcisions performed prior to study, 
median (range)
Surgical 150 (10 - 200)
Unicirc 0 (0 - 10)
Ease of performance, n (%)
Unicirc much easier 0
Unicirc easier 4 (100)
Neutral 0
Surgical easier 0
Surgical much easier 0
Method of preference, n (%)
Strongly prefer Unicirc 2 (50)
Prefer Unicirc 2 (50)
Neutral 0
Prefer surgical 0
Strongly prefer surgical 0
Glove perforations during the study, n (%)
   0 1 (25)
   1 2 (50)
   2 0
   >10 1 (25)
Table 6. Post-study case series of subsequent Unicirc 
circumcisions (N=50)
Intraoperative suturing, n 0
Blood loss (ml), median 1.5
Operative time (min), median 9
Complete follow-up, n (%) 50 (100)
Serious post-operative complication, n 0
Post-operative bleeding, n (%)
Mild (dressing only) 0
Moderate (sutured) 1 (2)
Haematoma, n (%) 1 (2)
Post-operative infection (antibiotic-treated), 
n (%)
2 (4)
Wound disruption at any point in time 
(cm length), n (%)
<2 2 (4)
>2 0
Healed at 4 weeks, n (%) 49 (98)
Cosmetic appearance, n
Regular 50
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